Nuron secures option, license deal to develop NU400 for RRMS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Nuron secures option, license deal to develop NU400 for RRMS

Postby MSUK » Fri May 27, 2011 2:36 am

Image

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has secured an exclusive option and license agreement utilizing PolyTherics' site-specific TheraPEG™ PEGylation technology to develop NU400, a long-acting version of Nuron's proprietary recombinant human interferon beta-1b (NU100).

PEGylating NU100 can also potentially improve other properties including its solubility, stability and safety profile. NU100 is poised to enter Phase 3 clinical studies in 2011 based on recent positive regulatory advice from the European Medicines Agency (EMEA).... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2872
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2121
Joined: Wed Oct 14, 2009 3:00 pm

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service